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Chapter 24 
Avian Chlamydiosis 
Daisy Vanrompay 
Introduction 
Definition and Synonyms 
Avian chlamydiosis (AC) is defined as an infection with a Chlamydia species in birds. 
The taxonomy of the family Chlamydiaceae was recently revisited. The genus Chlamydia 
includes currently 11 recognized species, and among them C. psittaci, C. avium, C. 
gallinacea and occasionally C. abortus have been isolated from birds (34, 75, 81, 89).  
Avian chlamydiosis is a respiratory disease, usually systemic and occasionally fatal. 
This chapter primarily covers current knowledge on Chlamydia psittaci infections as they 
occur in birds raised commercially for meat and egg production. It should be noted that 
the disease in pet birds is quite similar, and the disease characteristics, transmission, and 
diagnosis are essentially the same.  
Chlamydia psittaci can be transmitted to humans. The disease in birds and humans 
originally was called psittacosis or parrot fever because it was first recognized in 
psittacine birds and in humans associated with psittacine birds. Today we speak of 
chlamydiosis in birds and psittacosis in humans. 
Public Health Significance 
The strains of avian chlamydiae can infect humans and should be handled with 
appropriate biosafety and containment procedures. Risk assessment and management are 
essential when performing diagnosis of AC. Adequate information, communication, and 
health surveillance by an occupational physician are recommended (19, 82).  
Most infections occur through inhalation of infectious aerosols. While the disease 
from psittacine birds is best known, the infection in poultry is of particular concern as 
transmission to humans is common during handling and slaughter of the birds (20, 21, 42, 
46, 48, 49). Post-mortem examinations of infected birds and handling of cultures should 
be done in certified Class II laminar flow hoods whenever possible or with proper 
protective equipment. Appropriate zoonotic agent decontamination procedures should be 
followed because human infection can result from transient exposures. The incubation 
period is usually 5–14 days; however, longer incubation periods are known. Human 
infections vary from inapparent to severe systemic disease with interstitial pneumonia 
and encephalitis. The disease is rarely fatal in properly treated patients; therefore, 
awareness of the danger and early diagnosis are important. Infected humans typically 
develop headache, chills, malaise and myalgia, with or without signs of respiratory 
involvement. Pulmonary involvement is common. Auscultatory findings, however, may 
appear to be normal or to underestimate the extent of involvement. Diagnosis can be 
difficult and in the past was usually established through testing paired sera for antibodies 
to chlamydia by the complement fixation (CF) test. However, some patients remain 
seronegative although being hospitalized due to psittacosis. Thus, serology is more and 
more being replaced by nucleic acid amplification techniques (NAAT’s), also because 
they allow bird source tracing. In humans, tetracycline, doxycycline, or azithromycin are 
usually the drugs of choice unless contraindicated. The length of treatment will vary with 
the drug, but should be continued for at least 14 days for tetracycline. Secondary spread 
among humans rarely occurs (124). Because the disease is rarely fatal in properly treated 
patients, awareness of the danger and early diagnosis are important. 
History 
The first description of a psittacosis outbreak dates from 1879 and was described by 
Jacob Ritter, linking the disease to pet parrots and finches (72). Historical aspects of 
chlamydia-related diseases in animals and humans are reviewed by Pospischil (69). 
Etiology 
Classification 
The members of the family Chlamydiaceae, order Chlamydiales are obligate, intracellular 
Gram-negative bacteria. In 1999, Everett et al. (25) proposed a reassignment from the 
single genus Chlamydia into 2 genera, Chlamydia and Chlamydophila, based on 
clustering analyses of the 16S rRNA and 23S rRNA genes (Table 24.1). However, recent 
comparative genome analyses are consistent with the conclusion that host-divergent 
strains of chlamydia are biologically and ecologically closely related (45, 85). The 
previous taxonomic separation of the genus based on ribosomal sequences is neither 
consistent with the natural history of the organism revealed by genome comparisons. 
Consequently, the taxonomy of the family Chlamydiaceae was recently revisited. The 
genus Chlamydia includes currently 11 recognized species, namely C. abortus (sheep, 
goats, cattle), C. caviae (guinea-pigs), C. felis (cats), C. muridarum (mouse, hamster), 
C. psittaci (birds and others), C. pecorum (sheep, cattle), C. pneumonia (human and 
others), C. suis (swine), C. trachomatis (human) and two recently established species 
isolated from birds, C. avium and C. gallinacea (75), (Table 24.1).  
Table 24.1. Chlamydiaceae taxonomy. 
Chlamydial taxonomy in the 
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Chlamydial taxonomy used in the 21st 
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Chlamydial 
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Parachlamydiaceae, 
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Genus Chlamydia Chlamydia Chlamydophila Chlamydia 
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C. 
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a biovar 
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a biovar 
  C. 
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 C. 
pneumoni
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  C. 
pneumoni
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C. 
pneumoni
ae 
TWAR 
biovar 
  Koala 
biovar 
   Koala 
biovar 
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  Equine 
biovar 
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biovar 
 Equine 
biovar 
 C. psittaci Avian 
subtype 
  C. psittaci  C. psittaci  
  Abortion 
subtype 
  C. abortus  C. abortus  
  Feline 
subtype 
  C. felis  C. felis  
  Guinea-
pig 
subtype 
  C. caviae  C. caviae  
 C. 
pecorum 
   C. 
pecorum 
 C. 
pecorum 
 
 
Morphology  
The 4 morphologically distinct forms of chlamydia are termed elementary body (EB), 
reticulate body (RB), intermediate body (IB) and the persistent aberrant body. The EB 
(Figure 24.1) is a small, electron-dense, spherical body, about 0.2–0.3 mm in diameter. 
The EB is the infectious form of the organism, which attaches to the target epithelial cell 
and gains entry. The EBs have a highly electron-dense nucleoid located at the periphery 
of the EB and clearly separated from an electron-dense cytoplasm. Following entry into 
the host cell, the EB expands in size to form the RB, which is the intracellular, 
metabolically active form. The RB measures approximately 0.5–2.0 mm in diameter 
(Figure 24.2). The RB divides by binary fission and thereafter matures into new EBs. 
During this maturation, morphologically intermediate forms (IB), measuring about 0.3–
1.0 mm in diameter, can be observed. The IB has a central electron-dense core with 
radially arranged individual nucleoid fibers surrounding the core. Cytoplasmic granules 
are tightly packed at the periphery of the IB and are separated from the core by a 
translucent zone.  
Chlamydiaceae also can engage in a long-term relationship with the host cell, a 
phenomenon known as persistence, in which no visible growth of the chlamydial 
organisms can be observed. The normal developmental cycle can be interrupted in vitro 
by a number of conditions and agents, such as antibiotics, nutrient deprivation, or 
immune factors, interferon-gamma (IFN-γ) in particular. This is generally accompanied 
by the development of relatively small inclusions, enlarged pleiotrophic RBs, which are 
named aberrant bodies, and inhomogeneity of the inclusions. Aberrant bodies accumulate 
chromosomes, but genes for cell division are no longer expressed. Once the stress-
inducing factor is removed, aberrant bodies revert to normal RBs, complete the 
developmental cycle, and generate infectious EBs 
 
 
Figure 24.1. Buffalo green monkey (BGM) cell culture, 1 hour after inoculation with the C. psittaci Texas 
Turkey genotype D strain showing an elementary body (EB) attached to the side of a host cell microvillus. 
 
Figure 24.2. Buffalo green monkey (BGM) cell culture, 18 hours after inoculation with a C. psittaci 
genotype B strain (89/1326). Note the vacuole near the nucleus (N) with an early and late stage of division 
of a reticulate body (R). Note the “hour-glass” profile (arrow H). 
 
 
Antigenic Structure  
The cysteine-rich major outer membrane protein (MOMP) is well studied. It has a 
molecular weight of 40 kDa and represents approximately 60% of the weight of the outer 
membrane. The MOMP of C. psittaci is an immunodominant protein, and there is 
considerable evidence that antibodies to surface-accessible epitopes of MOMP have a 
protective role in immunity to chlamydial infection (23). The outer membrane protein A 
(ompA) gene (formerly referred to as omp1 gene) encodes the MOMP. The ompA gene 
contains 5 conserved- and four variable-sequence regions, VS1–VS4, which encode for 
the variable-protein domains VDI–VDIV. VDI, VDII, and VDIV especially protrude 
from the C. psittaci membrane. Epitope mapping has shown the presence of genus- and 
species-specific antigenic determinants within the conserved regions. However, species-
specific antigenic determinants also have been found in the most conserved parts of 
VDIV. Serovar-specific antigenic determinants are located within VDI and VDII. 
Monoclonal antibodies to the highly immunoaccessible serovar-specific epitopes on the 
MOMP can passively neutralize chlamydial pathogenicity and infectivity. Monoclonal 
antibodies to genus-, species-, or serovar-specific epitopes on the MOMP are excellent 
tools for specific chlamydial diagnosis. 
A chlamydial cysteine-rich heat shock protein 60 (hsp60 or GroEL) has been 
described that is cross-reactive with other Gram-negative bacteria such as Escherichia 
coli, Neisseria gonorrhoeae, and Coxiella burnetii (134). Thus, the presence of cross-
reactive epitopes on the chlamydial outer membrane should be kept in mind when 
choosing or interpreting a specific diagnostic test. 
Other chlamydia proteins under study are OmcA (EnvA or Omp3), OmcB (EnvB or 
Omp2), Hc1, RpoB', RpoB, PorB (OmpB), Omp85, elongation factor Tu (EF-Tu/TufA), 
DnaK (hsp70), OprB, heat shock proteins (10, 44, 58, 59, 61, 86, 93) and especially the 
recently discovered polymorphic outer membrane proteins (Pmps).  
Whole-genome sequencing has revealed the polymorphic membrane protein (Pmp) 
gene family. This is the largest protein family of Chlamydia species and it is a unique 
feature of the genus (40, 98, 103). Grouping of those proteins in one family is based on 
the conserved motifs FxxN and GGA (with I, L or V in the 4th position). The Pmps have 
been identified as autotransporter (type V secretion system) proteins, based on their 
cleavable N-terminal signal sequence (type II secretion) for translocation across the inner 
membrane, a central passenger domain which is responsible for the protein’s function and 
a C-terminal transporter domain that forms a β-barrel and with a phenylalanine at the 
end, which is suggestive for outer membrane localization, for translocation across the 
outer membrane (reviewed in 120). The Pmp may be involved in antigenic variation and 
contribute to immune evasion in the infected host. Recently, Van Lent et al., (104), 
studied the expression all 17 C. psittaci pmp coding sequences of the Cal10 strain during 
both normal and persistent culture conditions. They also used immunofluorescence 
staining and immuno-electron microscopy. PmpA and PmpH emerged as important 
players in C. psittaci pathogenesis by virtue of their unique expression properties, both at 
the transcript and protein level. 
The chlamydial lipopolysaccharide (LPS) also is an essential constituent of the outer 
membrane and, like the MOMP, represents one of the major surface-exposed antigens of 
chlamydiae in both the EB and the RB. It has a molecular weight of 10 kDa and is 
chemically and serologically related to the LPS of Gram-negative Enterobacteriaceae. In 
fact, the chlamydial LPS contains several antigenic determinants cross-reacting with the 
LPS of enterobacterial Re mutants of Salmonella species and Acinetobacter calcoaceticus 
(11, 62). However, the chlamydial LPS contains in its saccharide moiety a trisaccharide 
of 3-deoxy-D-manno-2-octulosonic acid (Kdo) of the sequence αKdo(2→8)-αKdo-
(2→4)-αKdo. This antigenic epitope is shared only by all members of the genus 
Chlamydia and, thus, represents a Chlamydiaceae-specific antigen useful for specific 
diagnosis (12). 
Strain Classification 
Antigenicity 
All Chlamydiaceae are recognized by monoclonal antibodies (MAbs) that detect the LPS 
αKdo(2→8)-αKdo-(2→4)-αKdo. Chlamydia species have a common antigenic epitope in 
variable segment 4 of the MOMP: NPTI, TLNPTI, LNPTIA, or LNPTI. C. psittaci 
strains are recognized by serovar-specific monoclonal antibodies. The 8 known C. 
psittaci serovars (A–F, M56, and WC) can be distinguished by use of a panel of serovar-
specific monoclonal antibodies in a micro-immunofluorescence test (4, 117). However, 
serotyping is currently seldom performed because the serovar-specific MAbs are not 
provided by a commercial supplier and because serotyping appears less discriminatory 
compared to the newly developed molecular characterization methods (28). 
Genetic, Molecular 
Chlamydia species can be distinguished by analysis of: (1) full-length 16S and 23S 
rDNAs, (2) the 16S-23S intergenic spacer (rrn spacer), (3) signature sequences in the 16S 
and 23S ribosomal genes (25, 26), (4) the Chlamydiaceae RNase P RNA gene (rnpB) 
encoding a ribonucleoprotein complex that removes 5' leader sequences from tRNA 
precursors during tRNA biosynthesis (38), or (5) the outer membrane protein A (ompA) 
gene encoding the chlamydia major outer membrane protein (MOMP). Polymerase chain 
reaction (PCR)-restriction fragment length polymorphism (RFLP), nested (multiplex) 
PCR, TaqMan-based real-time PCR, micro arrays, PCR followed by high resolution melt 
(HRM) curve analysis of the amplified 16S rRNA gene, as well as gene sequencing has 
been described for identifying Chlamydia species in livestock (26, 29, 57, 73, 78, 79, 80, 
109). 
OmpA genotyping by real-time PCR using genotype-specific probes is very often 
used. It allows the detection of an additional variant described as the avian C. psittaci 
genotype E/B (28). A few years ago, a genotyping micro array was introduced, allowing 
the identification of all currently known avian and mammalian C. psittaci genotypes (98). 
Genotyping is very convenient because it is a rapid, powerful technique that can be used 
directly on clinical samples in any veterinary clinical laboratory. 
Some avian ompA genotypes appear to occur more often in a specific order of birds. 
Genotype A, for instance, is endemic among psittacine birds (Psittacidae) but it also has 
been found in turkeys, ducks, pigeons, and Passeriformes. Genotype B is endemic in 
pigeons (Columbiformes) but also can infect chickens, turkeys, ducks, Psittacidae, and 
Passeriformes (4). Waterfowl (Anseriformes), such as ducks and geese, most frequently 
seem to be infected with genotype C. Genotype C also has been detected in chickens, 
ducks and pigeons (22, 42, 136). Genotype D strains are most often associated with 
turkeys, but they can also infect pigeons. More recently, genotype D has been detected in 
chickens (21). Genotype E, also known as Cal-10, MP, or MN, was first isolated during 
an outbreak of pneumonia in humans during the early 1930s. Later on, genotype E 
isolates were obtained from a variety of bird species including turkeys, pigeons, ducks, 
ostriches, and rheas. Genotype F is represented by the psittacine isolates VS225, Prk 
Daruma, 84/2334 (110), and 10433-MA, but has also been isolated on a Belgian turkey 
farm (108). Genotype E/B is often found in ducks, but it has also been detected in parrots 
(35), turkeys (100), and pigeons (30). The mammalian M56 and WC genotypes were 
isolated during an outbreak in muskrats and hares and during an outbreak of enteritis in 
cattle, respectively. Subgroups for three of the more heterogeneous genotypes have been 
introduced, i.e. A-VS1, A-6BC, A-8455, EB-E30, EB-859, EB-KKCP, D-NJ1, D-9N, 
and provisional genotypes to cover the strains that were previously non-typable have 
been suggested (77). All genotypes should be considered to be readily transmissible to 
humans.  
Pannekoek et al. (66) used multi-locus sequence typing (MLST) for studying the 
population structure of C. psittaci and C. abortus because Van Loock et al. (110) showed 
that ompA sequencing and even sequencing of the rrn spacer (25, 26) cannot always 
distinguish C. psittaci from C. abortus. The obtained MLST scheme was based on the 
partial sequences of 7 housekeeping genes, enoA, fumC, gatA, gidA, hemN, hflX and 
oppA, representative for the whole genome sequence. MLST of C. psittaci strains 
resulted in 11 unique sequence types (STs). MLST was extremely useful for 
distinguishing the phylogenetic highly related species C. psittaci and C. abortus. 
Interestingly, according to MLST, the ompA genotype F strain 84/2334 appears to be a C. 
abortus strain instead of a C. psittaci strain (66).  
According to Wang et al. (125), high-resolution genotyping within one chlamydia 
species can be achieved by multi-locus variable-number tandem-repeat (VNTR) analysis 
(MLVA) in combination with ompA sequencing (MLVA-ompA). This method is highly 
accurate for distinguishing closely related strains within one Chlamydia species. VNTR 
analysis was used for exploring the diversity of C. psittaci. For C. psittaci, 20 selected 
genetic loci were initially tested on 9 avian reference strains including representatives of 
all major ompA genotypes (A to F and E/B). Thereafter, 8 loci were retained for a more 
complete study performed on more than 150 C. psittaci isolates from different bird 
species and geographical origins. The MLVA system provides an additional level of 
discrimination within the C. psittaci species, with 20 distinct patterns identified to date 
(50). MLVA could provide the high resolution needed for local epidemiology and 
accurate contact tracing in cases in which zoonosis is contracted from poultry. However, 
current MLVA (and MLST) methods are still easier to perform on culturable samples or 
clinical samples of C. psittaci- infected poultry with a high bacterial DNA load. 
Conserved synteny, i.e. sequence and gene order conservation, in a genome of reduced 
size is recognized as a hallmark of the genus Chlamydia (31). Comparative genomics of 
C. psittaci has already revealed a number of characteristic features (15, 71, 105, 128, 
136). 
Pathogenicity 
Chlamydia psittaci strains isolated from birds fall into two general categories: (1) Highly 
virulent strains that cause acute epidemics in which 5%–30% of affected birds die and (2) 
less virulent strains that cause slowly progressive epidemics. Strains of both high and low 
virulence appear to have equal ability to spread rapidly through a flock, as evidenced by 
serologic test results. Highly virulent strains are isolated often from turkeys, ducks, 
pigeons, and more recently also chickens. They also appear in clinically normal wild 
birds. 
Highly virulent strains have been characterized in European turkeys (118), ducks (48, 96) 
and more recently also in chickens (49,132). So far, genotypes B, C, F and E/B have been 
found in chickens (22, 27, 136, 137).  
Highly virulent strains cause rapidly fatal disease in natural and experimental hosts 
with lesions characterized by extensive vascular congestion and inflammation of vital 
organs. Highly virulent strains have a broad spectrum of pathogenicity for laboratory 
animals and can cause serious human infections (some fatal) in poultry handlers and 
laboratory research workers. Strains of low virulence cause slowly progressive epidemics 
with a mortality rate of less than 5% when uncomplicated by secondary bacterial or 
parasitic infection. Strains of this category are often isolated from pigeons and are also 
found in ducks, turkeys, chickens, sparrows, and other wild birds. The turkey isolates 
from outbreaks with low mortality have been of genotype B or E. Birds infected with 
these strains usually do not develop the severe vascular damage typical in birds infected 
with the virulent strains, nor do they have the severe clinical signs (94). 
Virulence Factors 
The initial event in the infectious process begins with attachment of C. psittaci EBs to 
microvilli at the apical surface of a susceptible columnar epithelial cell (39) (Figure 
24.1). The EB travels down the microvillus and locates in indentions of the eukaryotic 
plasma membrane, some of which resemble coated pits. The bases of micropilli represent 
areas of active transport of extracellular materials into the cells and, therefore, might 
assist rapid and efficient entry of EBs. After 1–3 hours, the EBs are internalized in 
invaginations of the plasma membrane. Uptake of C. psittaci is an endocytic mechanism, 
involving microfilament-dependent and/or independent processes. The C. psittaci 
containing endocytic vesicles or vacuoles escape interaction with lysosomes and proceed 
in about 8–12 hours to the nuclear area, where EBs are converted to RBs. Conversion to 
RBs primarily involves reduction of disulfide bond cross-linking among the outer 
membrane proteins altering the EB cell wall. Synthesis of DNA, RNA, and proteins is 
initiated, permitting growth and binary fission of the RBs. Binary fission is characterized 
by the appearance of typical “hourglass” profiles inside the vacuole (Figure 24.2). The 
enlarging vacuole also is termed an “inclusion.” 
C. psittaci microorganisms do not always remain within the inclusion throughout their 
intracellular development. In some cases, and in apparent correlation with high virulence 
of strains, the inclusion membrane seems to degrade during the active multiplication, 
liberating the bacteria into the cytoplasm of the host cell (111). About 30 hours after 
internalization of the EB, the first RBs are reorganized into newly formed EBs. At about 
48–50 hours, the developing chlamydial inclusion may contain anywhere from 100–500 
progeny, depending on the characteristics of the C. psittaci strain (Figure 24.3). With 
most C. psittaci strains, the host cell has undergone severe degenerative changes, and 
microorganisms are released by lysis (Figure 24.4). Exocytosis of the inclusion, followed 
by a “healing” or closing of the open-cavern structures where the inclusion had existed, 
has been reported (111). Persistent infections may occur with non-replicating RBs, the so 
called aberrant bodies, remaining inside the host cell cytoplasm. 
 
Figure 24.3. BGM cell culture, 52 hours after inoculation with a C. psittaci genotype D strain (92/1293), 
isolated from diseased turkeys. Note the large inclusion and the elementary bodies (EB) apparently 
“escaping” from the inclusion. Also notice the mitochondria (M) lining the inclusion. 
 
Figure 24.4. BGM microcarrier culture, 50 hours post inoculation with the C. psittaci Texas Turkey 
genotype D strain showing lysis of an infected BGM cell. The cell is sloughing off the microcarrier (MC). 
Note the presence of elementary bodies (E), reticulate bodies (R), and intermediate bodies (I). 
Long, unique, rosette-like structures and projections have been observed on the 
surface of both EBs and RBs of C. psittaci strain Mn (56). Shortly after the first 
description of a type III secretion system (T3SS) in C. caviae (GPIC strain) (41), Bavoil 
and Hsia (5) speculated that Matsumoto’s projections are in fact functional T3SSs, 
injecting chlamydial virulence proteins into the host cell cytoplasm. Chlamydia psittaci 
strains also contain a type three secretion system (T3SS) (8). Beeckman et al., (8) 
identified a T3SS in a virulent C. psittaci genotype D strain isolated from turkeys and 
studied its possible role in virulence. 
Outer virulence factors under study are the polymorphic membrane proteins (Pmps) 
(93). The Pmps belong to the family of autotransporter proteins (type V secretion 
system). Most autotransporter proteins contribute to the virulence of many Gram-
negative pathogens. Specific roles in pathogenesis have been described, including 
adhesion, host and tissue tropism and antigenic variation (immune evasion) (6, 58, 92, 
126). Additional potential functions of the Pmp proteins still need to be examined.   
 
Pathobiology and Epidemiology 
Incidence and Distribution 
Avian chlamydiosis occurs worldwide, with the incidence and distribution varying 
greatly with the species of bird and the genotype of the chlamydial organism. Antibiotics 
have been used extensively to control the spread of the disease in birds and to reduce the 
risk to humans.  
The disease pattern in turkeys has changed. Historically, most outbreaks were 
explosive and occurred in free-ranging birds. These severe respiratory disease outbreaks 
were attributed to genotype D. Chlamydia was thought to have been introduced from the 
outside. Today, genotype D and sometimes genotype A are found in confinement turkeys 
when death losses are high; genotype B is less virulent (4, 74). Introduction through 
vertical transmission (55, 127) or through infected hatchlings (20) may occur. Studies on 
turkeys in Belgium and France showed that strains (genotypes A, B, D, E, E/B, and F) of 
high and low virulence are widely distributed in commercial turkeys and may be 
endemic. Chlamydia is part of the turkey respiratory disease complex (108). Infection of 
turkey broilers with C. psittaci also seems to predispose animals to more severe clinical 
outcomes of a simultaneous or subsequent infection with Escherichia coli, the avian 
metapneumovirus and/or Ornithobacterium rhinotracheale (106, 107, 108).  
Over the last decade, Chlamydia psittaci infections in ducks seem to be reported more 
often in China and Europe (14, 16, 32, 52, 97, 131, 132) than in the US. In Europe, the 
number of outbreaks in ducks seems to be increasing as well as the number of zoonotic 
case reports linked to handling ducks (42, 48, 123). This could be due to reduced 
antibiotic use in poultry or to the occurrence of more virulent C. psittaci strains. 
European isolates have been characterized as genotype C and genotype E/B (28, 42, 48). 
In China, genotypes A and C have been found in ducks (83, 131).  
C. psittaci outbreaks on chicken farms and zoonotic transmissions linked to contact 
with C. psittaci-infected chickens have also appeared to occur more frequently over the 
last decade (17, 20, 21, 27, 33, 46, 49, 73, 131, 132). In one study by Verminnen at al 
(122) the author investigated the occurrence of C. psittaci by performing a retrospective 
study of 300 serum samples collected in 2005 from 10 randomly selected chicken 
breeder, broiler, and layer farms in Belgium. Sera were examined using a recombinant 
MOMP-based enzyme-linked immunosorbent assay (ELISA). Seropostive results were 
obtained from 98%, 95%, and 95% of layers, broilers, and breeders, respectively (21), 
and seropositive birds were found on all farms. Highly virulent genotype A and D strains, 
as well as genotypes B, C, F and E/B have been found in chickens in Belgium, China, 
France, and Germany (27, 46, 49, 132, 135, 137). 
In 2008, 3 cases of atypical pneumonia in individuals working at a French 
slaughterhouse processing guinea fowl, ducks, and especially chickens prompted an 
epidemiologic survey of the 10 farms that had supplied the birds. Using a 
Chlamydiaceae-specific real-time PCR assay, chlamydial agents were detected in 14 of 
the 25 investigated flocks. In one duck flock studied, 20% of the tested animals were 
positive. Additionally, 12 of 18 (67%) and 1 of 6 (17%) of the chicken and guinea fowl 
flocks examined were PCR positive, respectively. Positivity for the chicken flocks ranged 
from 10%-100%. For the positive guinea fowl flock, 12.5% of the tested animals were 
positive. Rather unexpectedly, Chlamydia psittaci was identified only in the positive 
duck flock, whereas ArrayTube DNA microarray testing indicated the presence of a new 
chlamydia agent in of all the other French poultry flocks that were examined. Further 
studies on the agent found in chickens revealed the presence of a new member of the 
family Chlamydiaceae namely C. gallinacea sp. nov. (49, 75). 
Data on C. psittaci infections in meat-type pigeons are primarily published in China. 
An indirect haemagglutination assay (detects Chlamydiaceae) was used to examine the 
seroprevalence of C. psittaci infections in Guangdong. Seroprevalence was 17% (34/200) 
in meat-type pigeons obtained from seven commercial flocks (53). Occupationally 
contracted psittacosis was reported after contact with meat-type pigeons in Beijing. 
Employees of pigeon farms in Beijing were diagnosed as psittacosis by positive CFT and 
recovered after treatment with erythromycin (131). 
 
 
Natural and Experimental Hosts 
Chlamydiae or chlamydial antibodies have been found in at least 465 bird species (43). 
Common reservoirs of chlamydiae include wild and feral birds such as sea gulls, ducks, 
Canada geese, herons, egrets, pigeons, blackbirds, grackles, house sparrows, and killdeer, 
all of which freely intermingle with domestic birds (51). Highly virulent strains of C. 
psittaci can be carried by and excreted in large numbers without any apparent effect on 
these hosts. 
Experimental hosts of avian chlamydiae can include virtually any species of bird. 
Mammalian laboratory hosts used for avian chlamydiae are principally mice and 
occasionally guinea pigs. Mice and guinea pigs are the natural hosts for C. muridarum 
and C. caviae, respectively. Investigators using these animals should determine the 
chlamydial status of the breeding stock. Rabbits are refractory to clinical disease caused 
by avian chlamydiae, but they may be used to produce polyclonal antibodies. 
Younger domestic birds generally are more susceptible than older birds to infection, 
clinical disease, and mortality. However, maternal antibodies might protect against 
respiratory disease outbreaks on the farm. Infection in old turkeys, such as spent breeder 
hens, can go unnoticed unless birds are subjected to stressful conditions such as shipment 
to market on crowded trucks. Turkey toms may have a higher mortality rate than turkey 
hens. 
Transmission, Carriers, and Vectors 
Transmission of C. psittaci primarily occurs from one infected bird to another susceptible 
bird in close proximity. The agent is excreted in feces and nasal discharges. Fecal 
shedding occurs intermittently and can be activated through stress caused by nutritional 
deficiencies, prolonged transport, overcrowding, chilling, breeding, egg laying, treatment, 
or handling. Bacterial excretion periods during natural infection can vary depending on 
virulence of the strain, infection dose, and host immune status. However, shedding may 
occur for several months. Transmission of chlamydiae occurs primarily through 
inhalation of contaminated material and, sometimes, ingestion. 
Large numbers of C. psittaci cells can be found in respiratory tract exudate and fecal 
material of infected birds. The importance of the respiratory exudate in transmission has 
become more apparent. In turkeys, the lateral nasal glands become infected early and 
remain infected for more than 60 days. Choanal/oropharyngeal swabs are more consistent 
for isolation of the agent than fecal swabs, especially during early stages of infection. 
Direct aerosol transmission through aerosolization of respiratory exudate must be 
considered as the primary method of transmission 
Avian species, including domestic poultry sharing aquatic or moist soil habitats with 
wild infected aquatic birds, may become infected via contaminated water. Granivorous 
birds, like pigeons, doves, pheasants, and house sparrows, may become infected by dust 
inhalation in barnyards and grain storage sites contaminated by feces. The consumption 
of infected carcasses may transmit C. psittaci to host species that are predators or 
scavengers of other birds. 
Transmission of C. psittaci in the nest is possible. In many species, such as 
Columbiformes, cormorants, egrets, and herons, transmission from parent to young may 
occur through feeding by regurgitation, while contamination of the nesting site with 
infective exudates or feces may be important in other species, such as snow geese, gulls, 
and shorebirds. Furthermore, C. psittaci can be transmitted from bird to bird by 
bloodsucking ectoparasites such as lice, mites, and flies or, less commonly, through bites 
or wounds. Transmission of C. psittaci by arthropod vectors may be facilitated in the 
nest. Mites from turkey nests can contain chlamydiae (23) and during an epidemic in 
turkeys in South Carolina, simulid flies were suspected as a possible method of transfer 
(64). Transmission through insects is indeed not unlikely as a recent study by Pilloux et 
al., (68), demonstrated a high prevalence and variety of Chlamydiales DNA within Ixodes 
ricinus ticks.  
Vertical transmission has been demonstrated in turkeys, chickens, ducks, parakeets, 
seagulls, and snow geese, although the frequency appears to be fairly low (55, 127). 
However, it could serve as a route to introduce chlamydiae into a poultry flock. Recently, 
experimental evidence was presented for the transmission of C. psittaci in poultry by 
eggshell penetration (1).  
Chlamydia psittaci can be introduced into poultry through the wild bird population. 
Contaminated feed, barn bedding or equipment also can be a source of infection, and feed 
should therefore be protected from wild birds. Careful cleaning of equipment being used 
in several barns during one and the same production round is extremely important 
because C. psittaci can survive in feces and bedding for up to 30 days (34).  
Incubation Period, Clinical Signs, Morbidity and Mortality, Pathology, and 
Pathogenesis 
Turkeys 
Vanrompay et al. (113) used immunodetection to study the pathogenesis of C. psittaci 
genotype A, B, and D strains in specific pathogen free turkeys. Use of immunodetection 
allowed precise determination of tissue and cell tropism. In this study, turkeys were 
aerosol infected, because it represents the natural route of infection (65). From this study, 
the following pathogenic sequence of events can be deduced for all three genotypes 
investigated. In turkeys infected by aerosol, the primary site of replication is the upper 
respiratory tract, where epithelial cells become infected. Subsequently, epithelial cells of 
the lower respiratory tract and macrophages throughout the respiratory tract become 
infected. Then, intense replication occurs in the respiratory tract. At the same time, 
chlamydiae can be demonstrated in plasma and monocytes, indicating septicemia, and 
chlamydiae appear in epithelial cells and macrophages of various tissues throughout the 
body. 
In turkeys, an experimental infection with a genotype B strain induced much milder 
clinical signs and lesions than infection with genotype A or D strains (115). The genotype 
B strain had a longer incubation period, took longer to reach maximum titers in the 
tissues, and had shorter periods during which the organism was found in the tissues. 
The incubation period of chlamydiosis in naturally infected birds varies, depending 
upon the number of chlamydiae inhaled, the virulence or pathogenicity of the infecting 
strain for that host species, and host immunogenetics. Experimentally, definitive disease 
signs in young turkeys receiving a virulent strain may be evident in 5–10 days. In birds 
naturally exposed to smaller doses or in older birds, the period may be longer. Strains of 
lower virulence, which cause less severe signs, may have longer incubation periods. 
Clinical signs may not be noticeable until 2–8 weeks after exposure. 
Signs of chlamydiosis in turkeys infected with virulent strains are cachexia, anorexia, 
elevated body temperature, conjunctivitis, and respiratory distress. Diseased birds excrete 
yellow-green, gelatinous droppings. Egg production of severely affected hens declines 
rapidly to 10%–20% and may temporarily cease or remain at a very low rate until 
complete recovery. Disease signs in a flock infected with strains of low virulence are 
usually anorexia and loose, green droppings in some birds, with less effect on egg 
production. 
At the peak of disease outbreak in a flock infected with a virulent strain, 50%-80% of 
the birds will show clinical signs, whereas morbidity from less virulent strains is only 
5%-20%. Mortality caused by virulent chlamydia ranges from 10%-30% and is only 1%-
4% with less virulent strains. 
The less virulent strains cause gross lesions, which are similar to those caused by 
virulent strains, only less severe and extensive. In overwhelming infections with virulent 
strains, lungs show diffuse congestion, and the pleural cavity may contain fibrinous 
exudate. In fatal cases, a dark transudate may fill the thoracic cavity. The pericardial 
membrane is thickened, congested, and coated with fibrinous exudate. The heart may be 
enlarged, and its surface may be covered with thick fibrin plaques or encrusted with 
yellowish, flaky exudate (Figure 24.5). The liver is enlarged and discolored and may be 
coated with thick fibrin. Air sacs are thickened and heavily coated with fibrinous exudate 
(Figure 24.6). The spleen is enlarged, dark, and soft and may be covered with gray-white 
spots representing areas of focal cellular proliferation. The peritoneal serosa and 
mesentery show vascular congestion and may be coated with foamy, white fibrinous 
exudate. All of these exudates contain large numbers of mononuclear cells in which 
numerous microcolonies of chlamydial RBs may be seen. Fibrinous exudates, found on 
all organs and tissues of the thoracic and peritoneal cavities, reflect vascular damage as 
well as increasing inflammatory response caused by the continued multiplication of the 
organisms. In birds that survive infection with a strain of low virulence, the lungs may 
not be seriously affected. However, multiplication of organisms on the epicardium may 
result in the formation of 1 or more fibrin plaques. 
Vanrompay et al. (112) examined histopathologic changes in 4 groups of 20 specific 
pathogen free (SPF) turkeys kept in isolation units and inoculated by the natural route of 
infection (aerosol). Turkeys were experimentally infected with strain 84/55 (C. psittaci 
genotype A), isolated from a parakeet, strain 92.1293 from a turkey (C. psittaci genotype 
D), the Texas Turkey strain (C. psittaci genotype D), or strain 89/1326 (C. psittaci 
genotype B) from a pigeon. All 4 strains proved to be pathogenic for SPF turkeys. 
Turkeys showed conjunctivitis, sinusitis, rhinitis, keratitis, pericarditis (Figure 24.5), 
pneumonia, airsacculitis (Figure 24.6), hepatosplenomegaly, enteritis, congestion of the 
kidneys, and congestion of the ovaries or testes. There were epithelial erosions and fibrin 
deposit in the conjunctivae (Figure 24.7), corneal ulceration, bronchopneumonia (Figure 
24.8), fibrinous necrotizing airsacculitis (Figure 24.9), fibrinous pericarditis, interstitial 
nephritis, peritonitis, and catarrhal enteritis. The type and distribution of the lesions was 
similar for genotypes A and D. However, the lesions produced after genotype A infection 
appeared more severe. For genotype B, in comparison with both other genotypes, no 
lesions were observed in the small intestine, pancreas, ovary, and testis. 
 
Figure 24.5. Turkey experimentally infected (aerosol) with a C. psittaci genotype A strain (84/55) isolated 
from the lungs of a budgerigar. Note the presence of serous fluid together with fibrin in the pericardial sac. 
 Figure 24.6. Turkey experimentally infected (aerosol) with a C. psittaci genotype A strain (84/55). Note 
the thickened abdominal airsac totally covered with fibrin cloths (arrow). 
 
Figure 24.7. Hematoxylin and eosin staining of experimentally infected turkeys. Conjunctiva with 
infiltration of lymphocytes and heterophils together with epithelial vacuolization and hyperplasia. ×172. 
 Figure 24.8. Hematoxylin and eosin staining of experimentally infected turkeys. Congested lung with 
infiltration of lymphocytes (arrow A) and dilated bronchi and parabronchi (arrow B). ×69. 
Controlled dual infections in SPF turkeys demonstrated the pathogenic interplay 
between C. psittaci, avian metapneumovirus, and E. coli. Escherichia coli is a 
predisposing factor for the outcome of a C. psittaci infection. It can increase the severity 
of a C. psittaci infection and can reactivate a latent C. psittaci infection (106). An aMPV 
infection during the acute phase of a C. psittaci infection aggravates the severity of 
clinical signs, macroscopic lesions, pharyngeal aMPV excretion, and histological tracheal 
lesions. However, no clear interaction was established after an MPV infection in latently 
C. psittaci-infected turkeys (107). 
 
Figure 24.9. Hematoxylin and eosin staining of experimentally infected turkeys. Fibrinous necrotizing 
airsacculitis. ×172. 
Chickens 
Epidemiologic evidence formerly indicated that chickens are relatively resistant to 
disease caused by C. psittaci. Acute infection progressing to disease and mortality only 
occurred in young birds, and the incidence of actual epidemics was very low. Most 
natural infections in chickens were believed to be inapparent and transient. However, C. 
psittaci strains isolated from turkeys caused similar pathology and mortality in chickens 
as in turkeys (88, 90).  
Recently, highly virulent C. psittaci strains have been isolated from the lungs of 
diseased chickens raised in Belgium, France, Germany, and China (27, 131, 132, 137). 
The strains obtained from Belgian and French farms belonged to genotypes D and B and 
could successfully be used to reproduce the disease in experimentally infected SPF 
chickens (132). Chickens showed conjunctivitis, rhinitis, pneumonia, fibrinous 
airsacculitis, fibrinous pericarditis, and hepatosplenomegaly. Histopathological lesions 
(133) and mortality was observed. 
Ducks and geese 
Chlamydiosis in domestic ducks is important both economically and as a public health 
hazard. Over the last decade, outbreaks are primarily reported in China and Europe (14, 
32, 33, 48, 49, 52, 131). Chlamydiosis in ducks is usually a severe, debilitating, often 
fatal disease in which young ducks develop trembling, imbalanced gait, and cachexia. 
They become anorexic with green, watery intestinal contents and develop a serous to 
purulent discharge from the eyes and nostrils causing the feathers on the head to become 
encrusted with exudate. As the disease progresses, the ducks become emaciated and die 
in convulsions. Morbidity ranges from 10%–80%, and mortality varies from 0–30% 
depending on age and the presence of concurrent infections. Recently, severe outbreaks 
associated with human disease were reported in France (48, 49).  
Incidental to studies of chlamydiosis in ducks, several investigators have observed C. 
psittaci antibodies or the disease in geese and have isolated C. psittaci from diseased 
tissues (2). Clinical disease and necropsy findings were similar to those in ducks. 
Pigeons 
Signs of uncomplicated chlamydiosis in meat pigeons are variable, but those that 
develop acute disease are anorexic, unthrifty, and diarrhetic (2, 137). Some develop 
conjunctivitis, swollen eyelids, and rhinitis. Respiratory difficulty is accompanied by 
rattling sounds. As disease progresses, birds become weak and emaciated. Mortality 
occurs. Recovered birds become asymptomatic carriers. Some birds progress through an 
infection showing no signs or, at the most, transient diarrhea before becoming carriers. 
Salmonellosis or trichomoniasis exacerbates the illness in chlamydia-infected carrier 
birds, inducing signs and lesions of acute disease. Gross lesions of uncomplicated 
chlamydiosis in pigeons are fibrinous exudates on thickened air sacs, the peritoneal 
serosa, and occasionally the epicardium. The liver is usually swollen, soft, and 
discolored. The spleen may be enlarged, soft, and dark. Greater than normal amounts of 
urates are seen in cloacal contents if catarrhal enteritis occurs. In less severe infections, 
only the liver or air sacs are involved. Some heavily infected shedders have no lesions. 
 
Pheasants, Quail, Guinea Fowl, Peacocks and Partridges 
Chlamydiosis has been reported in farm-raised pheasants, quail, peacocks, guinea fowl 
and partridges from all over the world (24, 42, 131). The clinical signs and lesions are 
similar to those seen in other birds (91). Morbidity and mortality can be very high, 
especially in young birds. Only few human infections have been reported during the last 
decade (42, 49, 130, 131) 
 
Immunity 
Natural immunity to chlamydia is generally poor and short-lived. As birds become older, 
however, they become more resistant to clinical disease, even though infection may 
occur.  
The immune response to chlamydia is a coordinated event in which innate immune 
cells, B cells and T cells, act in concert and each of these immune effectors have roles in 
recognizing different stages of the infection. To date, Chlamydia psittaci vaccine studies 
suggest that the ideal, efficacious chlamydia vaccine should induce CD4+ T helper 1 
(Th1), and CD8+ cytotoxic T cell responses (70). Humoral immune responses, albeit not 
considered as crucial, seem to contribute significantly to protection (121).  
Less is known about innate immune detection of C. psittaci. Beeckman et al. (7) 
determined the cytokine responses following C. psittaci infection of avian 
monocytes/macrophages. High IL-10 and no TGF-b responses were observed at 4 hours 
post inoculation. This could induce macrophage deactivation and NF-kB suppression, and 
thereby could dampen innate immunity and promote C. psittaci survival in macrophages. 
 
Diagnosis 
 
The preferred method for the identification of AC is no longer isolation and identification of 
the organism. Because of the time involved, the need for high-quality samples, the fact that 
some strains will never grow in vitro and the hazard to laboratory personnel (BSL3 
laboratory required), nucleic acid amplification tests (NAAT’s) are currently recommended 
for quick, sensitive and specific diagnosis. These include conventional and real-time 
polymerase chain reaction (PCR), DNA microarray-based detection and DNA sequencing. 
Culture, cytological staining, immunological staining, immunohistochemistry or antigen 
enzyme-linked immunosorbent assays (ELISA) can be used if NAAT’s are not available. 
Specimen Collection and Storage of Samples  
The following samples should be preferably collected: pharyngeal/choanal slit swabs in 
live birds experiencing respiratory disease (3, 112) and/or conjunctival swabs if indicated 
by the presence of conjunctivitis. Cloacal swabs or fresh feces are less optimal because 
chlamydial shedding is intermittent. In dead birds, especially lungs and thickened 
exudate-coated air sacs are most suitable but spleen, liver and free exudates can also be 
sampled.  
Specimens should be collected aseptically if willing to culture chlamydiae as 
contaminating bacteria can interfere with the isolation of chlamydiae. Proper handling of 
clinical samples is necessary to prevent loss of infectivity if culture is to be used. If 
specimens are used to inoculate cell cultures or embryonated eggs immediately, most 
diluents will be adequate; however, if the specimen is to be shipped and/or stored before 
analysis, a special chlamydia transport medium should be used (84,119). Samples in 
chlamydia transport medium can be stored for 1 or 2 days at 4°C prior to analysis. 
However, longer preservation needs to be done at -80°C. Chlamydiae in tissue specimens 
or yolk-sac suspension can be preserved almost indefinitely by storage at -80°C. 
 
Culture  
Preparation of Inoculum 
Prior to inoculation, samples must be treated properly. The processing of samples is 
similar for inoculation of cell cultures or embryonating eggs. Penicillin and tetracyclines 
should be avoided because they inhibit the growth of C. psittaci. 
A standard procedure is to prepare 20% tissue suspensions in phosphate bufferend 
saline (PBS). The suspensions are centrifuged (2,790 × g, 4°C) for 10 minutes. The 
supernatants are collected and 10 µl/ml streptomycin sulfate (streptomycin sulfate 1% 
w/v) and 20 µl/ml vancomycin (vancomycin 0.5 w/v) are added. If needed, 0.1% 
amphotericin B can be added. After 1 hour of incubation at room temperature, the 
suspensions are centrifuged for 30 minutes (2,790 × g, 4°C) and supernatants are 
immediately used for inoculation or stored at –80°C until use. Swabs in chlamydia 
transport medium are shaken for 1 hour at 4°C on a rocking platform, centrifuged (2,790 
× g, 4°C), and the supernatant immediately used or stored at –80°C until use. Fecal 
samples, although not preferably used for diagnosis because of the intermittent chlamydia 
shedding and the risk for false negatives, are processed as follows. A 20% suspension is 
made in PBS, and the suspension is shaken for 1 hour (4°C) on a rocking platform. 
Afterward, the suspension is sonicated for 10 minutes using an ultrasonic water bath. The 
supernatant is collected, and 10 µl/ml streptomycin sulfate (streptomycin sulfate 1% 
w/v), 20 µl/ml vancomycin (vancomycin 0.5 w/v), and 0.1% amphotericin B are added. 
The suspension is incubated at room temperature (1 hour) and subsequently centrifuged 
(2,790 × g, 4°C) for 30 minutes. The supernatant is collected and thereafter 
ultracentrifuged (45,000 × g, 4°C, 45 minutes). The supernatant is discarded, and the 
remaining chlamydia pellet is re-suspended in diluent and immediately used for 
inoculation or stored at –80°C until use. 
Cell cultures are the most common and convenient method for the isolation of C. 
psittaci. The most commonly used cell lines are Buffalo green monkey (BGM), Vero, 
McCoy, HeLa, and L-929, although a number of other cell cultures, such as chicken 
embryo fibroblasts, can be used. A study showed BGM to be the most sensitive, with 
Vero and L-929 listed as satisfactory (136). Standard cell culture medium is used, 
containing 5%–10% fetal calf serum and antibiotics like vancomycin, streptomycin, and 
amphotericin B because they do not inhibit the growth of C. psittaci. Cell culture harvest 
can be frozen at -80°C in sucrose phosphate glutamate (SPG) buffer (1/1; SPG/culture 
medium).  
The culture equipment must be suitable for: (1) preferably identification by 
immunofluorescence staining, (2) centrifugation (500-1,500 × g for 60 to 90 minutes) of 
the inoculum onto the monolayer at 37°C to enhance infectivity (eventually in the 
presence of diethylaminoethyl (DEAE), (3) possible blind passages at 3 or 6 days post 
inoculation to increase sensitivity of isolation, (4) examination of the sample 2–3 times 
during passage, and (5) protection of humans against possible infection. Small, flat-
bottomed vials (1-dram shell vials) or bottles with 12-mm diameter glass coverslips meet 
these requirements and are often used because the cell culture monolayer can be grown 
directly on the coverslip. Several vials are inoculated with each sample to permit fixing 
and staining at various times and to permit passages of negative samples after 6 days of 
incubation.  
Chlamydiae can be isolated from cells that are replicating normally. Most 
diagnosticians, however, prefer to use nonreplicating host cells for two reasons: (1) to 
provide increased nutrients for the replication of chlamydiae and (2) because 
nonreplicating cells can be maintained for longer periods for observation. Host-cell 
replication is suppressed most commonly using cycloheximide (0.5-2.0 mg/ml). 
Incubation is usually at 37°C–39°C, depending on the cell culture used. Disruption of the 
monolayer by freeze-thawing should be avoided because it can destroy C. psittaci. 
Some laboratories still use chicken embryos for primary isolation of chlamydiae. The 
standard procedure is to inject up to 0.3 ml of inoculum into the yolk sacs of 6-day-old 
embryos (136). Replication of chlamydia usually will cause the death of the embryo 
within 5–12 days after inoculation. If no deaths occur, two additional blind passages are 
usually made before calling the sample negative. Chlamydia infection typically causes 
vascular congestion of the yolk-sac membranes, which are harvested and homogenized as 
a 20% yolk-sac suspension. This suspension can be frozen (-80°C) to preserve the strain 
or inoculated into other eggs if needed or into cell culture monolayers. C. psittaci is 
usually identified by immunofluorescence staining of yolk-sac impression smears. 
Staining Cell Monolayers or Yolk-Sac Impression Smears 
The preferred method for fixing of the monolayer is to remove the medium, wash once 
with PBS, and fix with cold acetone for 10 minutes (-20°C). If the cell culture vessel is 
plastic, the monolayer can be fixed with a mixture of 50% acetone and 50% methyl 
alcohol or with 100% methyl alcohol. The preferred method for staining is the 
fluorescence method. With the fluorescence method, the fluorescein-conjugated anti-
chlamydia serum is applied to the glass slide and incubated for minimum of 30 minutes at 
37°C. The slides are then washed with PBS and deionized water, air dried, and mounted 
for use by a fluorescence microscope. Commercially fluorescently labeled monoclonal 
antibodies are available.  
 
Direct visualization - Cytological staining techniques 
Chlamydiae can be detected in smears of cloacal and/or conjunctival swabs and in 
impression smears of tissues (lung, liver, spleen, kidney and airsacs if enough material is 
available) by cytological staining such as Giemsa, Giménez, modified Giménez, Ziehl–
Neelsen and Macchiavello’s stains (13). The modified Giménez technique is most often 
used (2). However, none of the stains specifically detects chlamydia. They are all less 
sensitive than antibody-based antigen detection methods or specific NAATs. Therefore, 
use of a cytological staining is losing popularity. 
Antigen detection  
Immunological staining techniques 
Immunofluorescence staining can be used to detect chlamydiae in smears of cloacal 
and/or conjunctival swabs, in impression smears of tissues and in frozen tissue sections. 
Most commercial staining kits use FITC conjugated anti-LPS or anti-MOMP monoclonal 
antibodies and most of them are originally developed for detection of C. trachomatis in 
human specimens.  
Immuno-histochemical staining is used to detect chlamydiae in paraffin sections and 
to show the association of chlamydial agents and pathological lesions in tissues. 
Commercial anti-Chlamydia antibodies for immunohistochemistry are available and most 
of them detect the Chlamydial LPS. 
Antigen Enzyme-linked immunosorbent assays 
The ELISA has been extensively promoted in kit format for use in the diagnosis of 
human chlamydiosis. These test kits detect the lipopolysaccharide (LPS) antigen (group 
reactive) and will detect all species of Chlamydiaceae. In the past, a number of these kits 
have been tested for use in detecting chlamydiae in birds (116), but none of the kits has 
been licensed for detection of C. psittaci. One problem with some of these tests is that the 
chlamydial LPS shares some epitopes with other Gram-negative bacteria, and these 
epitopes can cross-react, resulting in a high number of false-positive results. This 
problem has been reduced or eliminated in more recently developed kits by careful 
selection of the MAbs used. These kits, however, still lack sensitivity because a few 
hundred organisms are still needed to give a positive reaction.  
Detection of nucleic acids 
Reagents designed to stabilise the DNA should be considered when a delay in processing 
the sample is anticipated (18). DNA samples can be prepared using inexpensive reagents 
or commercially available kits. 
In the last decade, real-time PCR has become the preferred method in diagnostic 
laboratories for its rapidity, high throughput, potential for quantification and ease of 
standardisation. Several real-time PCR’s for the detection of C. psittaci have been 
developed (29, 37, 67). This technology requires a fluorescent-labelled probe and special 
equipment, which increases costs. Its sensitivity is lower than that of the nested PCR (78, 
109) but contamination problems due to post-PCR carry over of DNA of a previous 
amplification round and labour are reduced as it is based on one reaction in a closed 
system. OmpA-based real-time PCR protocols were developed to differentiate between 
genotypes of C. psittaci (29, 36) and to distinguish C. psittaci from C. abortus (63). The 
PCR developed by Heddema et al (36) is also validated on a large number of human 
psittacosis samples and thus is helpful to trace infection sources of zoonotic transmission. 
Real-time PCR protocols are available for the specific detection of C. avium (139) and C. 
gallinacea (47). 
DNA microarray technology has also been used in the diagnosis of chlamydial infections 
in animals (78). The assay for detection and identification of Chlamydiaceae spp. is 
based on PCR amplification of the 23S rRNA gene and subsequent identification of 
Chlamydia species occurring in animals, including C. psittaci, C. avium and C. 
gallinacea, by hybridisation with species-specific probes. An extended version of the 
Chlamydiaceae DNA microarray allows for ompA-based genotyping of C. psittaci strains 
(77). 
Serology 
 
Serology alone is not particularly useful in diagnosing a current chlamydial infection in 
birds because of the high prevalence of this infection in birds and the long-term (up to 
several months) persistence of anti-chlamydial antibodies. In most bird species, there is a 
high background rate of anti-chlamydial antibodies in birds. Thus, to determine if a single 
bird is infected, serology should always be used in conjunction with antigen or gene 
detection, or paired sera should be examined. However, obligatory examination of paired 
sera removes serology from immediate clinical relevance. A positive test is evidence that 
the bird was infected by the bacterium but does not necessarily indicate an active 
infection. False negative results can occur in birds with acute infections that are sampled 
before seroconversion. Treatment with antibiotics also may delay and/or diminish the 
antibody response. The main serological method used for detecting chlamydial antibodies 
is the complement fixation test (CFT). However, the complement fixation test is more 
often being replaced by highly sensitive and specific ELISA’s based on the use of 
recombinant proteins (122) or peptide antigens (76). ELISA’s can detect avian IgM, IgG 
and IgA as long as the correct isotype-specific conjugate is used. 
 
Differential Diagnosis 
The signs of chlamydiosis in birds are non-specific and resemble those observed in many 
other diseases. Suspected chlamydiosis may have to be differentiated from pasteurellosis, 
particularly in turkeys, in which some signs and lesions may be similar. Pasteurellosis 
can be ruled out by appropriate culture procedures. Because of some similar signs and 
lesions, Ornithobacterium rhinotracheale infections and mycoplasmosis may need to be 
ruled out in turkeys and chickens suspected of having chlamydiosis. This can be 
accomplished by culturing and serologic testing. Colibacillosis may mimic chlamydiosis 
to some extent, but it can be excluded by the use of appropriate coliform culturing 
procedures. Avian influenza virus, paramyxoviruses, herpes viruses or aMPV may have 
to be ruled out in suspected chlamydiosis by virus isolation and serologic testing. 
Intervention Strategies 
Management Procedures 
Ideally birds should be reared in confinement without contact with contaminated 
equipment or premises. Contact with potential reservoirs or vectors such as pet birds, 
rodents, arthropods, and wild and feral birds also should be prevented. General sanitation 
must be practiced diligently. Movement of people should be restricted so that visitors do 
not have free access to premises holding birds. This is easier to accomplish if birds are 
confined in houses and if the “all-in-all-out” principle is used on the farm. 
A sensitive technique for Chlamydia psittaci bioaerosol monitoring is available. The 
air collection medium (ChlamyTrap) used can be examined by PCR or culture. The 
technique could be used for monitoring the infection pressure in the poultry industries 
(101). 
Susceptibility to Chemical and Physical Agents 
The survival of microorganisms in aerosols depends on five different factors: relative 
humidity (RH), temperature, level of oxygen, presence of UV radiation, and constituents 
of the aerosol and of air (95). The degree to which these factors influence the survival of 
microorganisms in aerosols depends strongly on the type of microorganism and the time 
it has to spend in the aerosol. In general, the following rule applies: Gram-negative 
bacteria survive best at low temperatures and RH. Thus, C. psittaci remains viable at low 
temperatures and is resistant to desiccation. The bacterium is highly susceptible to 
repeated freeze-thawing cycles and is destroyed within three minutes when exposed to 
UV-light. 
Chlamydiae are highly susceptible to chemicals that affect their lipid content or the 
integrity of their cell walls. Even in a milieu of tissue debris they are inactivated rapidly 
by surface-active compounds, such as quaternary ammonium compounds and lipid 
solvents (104). Infectivity is destroyed within minutes by exposure to common 
disinfectants such as benzalkonium chloride, alcoholic iodine solution, 70% ethanol, 3% 
hydrogen peroxide, and silver nitrate, but they are resistant to cresol compounds and 
lime. Dilute suspensions (20%) of infectious tissue homogenates are inactivated by 
incubation for 5 minutes at 56°C, 48 hours at 37°C, 12 days at 22°C, and 50 days at 4°C 
(88). 
Vaccination  
Commercial chlamydia vaccines for poultry are not available. Protective immunity to 
Chlamydiaceae is believed to be effected primarily through the action of CD4+ T helper 
type 1 (Th1) lymphocytes, CD8+ T lymphocytes, mononuclear phagocytes, and cytokines 
secreted by these cells. In addition, the role of antibodies is not to be underestimated. A 
protective chlamydial antigen that has been unambiguously identified is the major outer 
membrane protein (MOMP).  
This paragraph summarizes knowledge on C. psittaci vaccination experiments in poultry 
performed during the last decade. In light of current knowledge on protective chlamydial 
immunity, plasmid DNA expressing the MOMP of C. psittaci has been tested for its 
ability to raise a protective immune response in SPF turkeys against challenge with C. 
psittaci strains (121). Effective priming of T cell memory and significant reduction in 
clinical signs, lesions, bacterial excretion, and C. psittaci replication in tissues was 
observed. Zhou et al., (138) used a human adenovirus serotype 5 (AdEasyTM-1), which 
was rendered replication defective by the deletion of the E1 and E3 genes, to obtain a 
recombinant adenovirus containing the MOMP gene (rAd-MOMP) of a Chinese C. 
psittaci strain of chicken origin. Low mean serum antibody responses (determined by 
indirect haemaglutination assay) and extremely low mean stimulation indexes in the T 
cell proliferation assay were observed. The vaccine seemed to induce protection in SPF 
chickens based on the observed differences in pathology. Unfortunately, chlamydia 
excretion and replication in tissues was not examined in this study. More recently, Liu et 
al., (54), evaluated a recombinant HVT-delivered vaccine against C. psittaci and Marek's 
disease, expressing C. psittaci PmpD, in SPF chickens. Post challenge with 
C. psittaci CB7 strain, a significant decrease in respiratory distress, lesions and 
chlamydia load was found in the vaccinated group compared to the non-vaccinated 
controls. 
 
Prevention by Means of Ovotransferrin 
Ovotransferrin (natural anti-microbial protein) was successfully used to reduce clinical 
signs, lesions, excretion, and chlamydia replication in experimentally infected SPF 
turkeys (102). Also, C. psittaci infection pressure on a turkey broiler farm was 
significantly reduced by administering ovotransferrin aerosols. Ovotransferrin 
significantly reduced respiratory disease, mortality, and antibiotic use on the farm (99). 
Treatment 
Chlamydiosis treatment for poultry has not changed over the years (113). The drug of 
choice varies from country to country. Among tetracylines, which are the drugs of choice, 
chlortetracycline and doxycycline are most often used. Enrofloxacin (fluoroquinolone 
antibiotic) also can be used, although some countries decided to ban the use of this 
antibiotic in poultry because of the risk that it promotes drug-resistant bacteria that can be 
harmful to humans. 
Turkeys can be treated with chlortetracycline (CTC) at a concentration of 400 g/ton of 
pelleted feed. Care must be taken so that heat generated during pelleting does not destroy 
CTC and lower the active concentration below an effective level. The CTC-medicated 
feed must be given for 2 weeks and then replaced by nonmedicated feed for 2 days prior 
to the birds being slaughtered for human consumption. Calcium supplements should not 
be added to CTC-medicated pellets because calcium ions chelate CTC and diminish its 
effectiveness. Turkeys also can be treated with doxycycline hyclate formulations for 
drinking water (doxycycline hyclate 500 mg/g, dose of 20 mg/kg bodyweight/day) for 5 
days or enrofloxacin (100 mg/ml) at a daily dose of 10 mg of enrofloxacin/kg of 
bodyweight, in water, for 3–5 days and in case of mixed or chronic infections for 5–10 
days. Medicated drinking water should be replaced every 24 hours. It is recommended 
that all turkeys on the infected premises be treated. 
Essentially the same treatment methods are used to treat other fowl infected with C. 
psittaci. In other birds, salmonellosis may often be a complicating factor so it may be 
necessary to use a combination of antibiotics. Treatment may not be effective in 
eliminating the carrier state. Additional periods of treatment may be needed, especially 
when birds are kept for several weeks. 
State Regulations 
Because regulations may vary from country to country, the appropriate public health 
and/or animal health agencies should be consulted as necessary. In many countries, 
psittacosis (humans) and even chlamydiosis in poultry are notifiable diseases and must be 
reported within 48 hours. 
According to United States Department of Agriculture (USDA) regulations, 
movement of poultry, carcasses, or offal from any premise is prohibited where the 
existence of chlamydiosis has been confirmed by isolation of a chlamydial agent. The 
Animal and Plant Health Inspection Service (APHIS) of the USDA and the U.S. 
Department of Health and Human Services (US HHS) forbid interstate movement of 
birds from infected flocks, but there is no restriction on movement of eggs from such 
flocks, which is not wise considering the possibility of vertical and horizontal 
transmission of C. psittaci through eggs. The European legislation is similar and also 
rather vague on movement of eggs when C. psittaci is suspected or even proven. It states 
that the competent authority shall ensure that the measures necessary to avoid any spread 
of disease are taken, in accordance with the requirements of Union legislation governing 
measures to be taken against the disease in question and on trade in animals. 
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